FDA于2015年10月22日曾发布药品安全通讯:要求对降血钾药聚苯乙烯磺酸钠(sodium polystyrene sulfonate),也称“降钾树脂”(商品名Kayexalate)开展药物相互作用研究。但最新FDA对这一规定进行了更新,并于2017年9月6日发布一则新的药品安全通讯:建议...
Similar to Veltassa, Kayexalate may also bind to other oral medications, the FDA cautions. "To reduce this potential risk, prescribers and patients should consider separating Kayexalate dosing from other medications taken by mouth by at least 6 hours. This includes both prescription medications, ...
Drug Interactions Advise patients who are taking other oral medication to separate the dosing of KAYEXALATE by at least 3 hours (before or after) [seeDOSAGE AND ADMINISTRATION,WARNINGS ANDPRECAUTIONS, andDRUG INTERACTIONS] From
Serious side effects, including bowel necrosis, may occur with repeated or prolonged dosing (SOR: C, systematic review of case studies). Copyright 2020 by Family Physicians Inquiries Network, Inc. DOI 10.1097/EBP.0000000000000988doi:10.1097/EBP.0000000000000988Skiff, Amy...